EX-4.1
Consulting Agreement by and between the Company and Artius, | MATEON THERAPEUTICS INC | Business Contracts | Justia
Windlas Biotech and Mateon Therapeutics to launch combined lung therapy, AI Telemedicine solution - Express Healthcare
Mateon launches antiviral programme focussed on Covid-19
Mateon Therapeutics
Mateon | HealthWire
MATEON'S C001- A GLOBAL PHASE 2 STUDY FOR OT-101 AGAINST
EDGAR Filing Documents for 0001493152-21-001207
Mateon Therapeutics Archives - IndiaMedToday
Dr. Anthony E. Maida will be presenting at the Marcus Evans Evolution Summit
NantCell Binding Termsheet | MATEON THERAPEUTICS INC | Business Contracts | Justia
Mateon Halts Lead Candidate Development, Axes 60% of Workforce
Zacks Small-Cap Research
COVID Pandemic Hastens Search For New Technology And CRO Partner
Mateon Therapeutics Announces Termination of FOCUS Study in
Windlas Biotech, Mateon Therapeutics bring lung therapy food supplement PulmoHeal - FFOODS Spectrum - Unleashing the Power of Food Science & Technology
Mateon and PointR to merge into AI-driven oncology firm
Mateon Completes Its Acquisition of PointR Data Inc. - DATAVERSITY
Windlas Biotech and Mateon Therapeutics launch first-ever Drug-Device Lung Therapy Combined AI 360 platform for respiratory wellness - The Statesman
Mateon Therapeutics completes acquisition of PointR Data
Blockchain-Fueled Company Mateon Develops Phase 3 Clinical Drug Candidate, Against COVID-19 - OT-101 – Blockchain News, Opinion, TV and Jobs
Mateon Therapeutics - BIO Investor Forum | BIO
DEVELOPMENT UPDATE FOR ARTIVEDA™/ARTISHIELD™ AGAINST
Keeping an eye on Mateon Therapeutics (OTCQB: MATN) says GEN - Genetic Engineering & Biotechnology News - EmergingGrowth.com
Windlas Biotech, Mateon Therapeutics launch integrated solution for respiratory wellness in India
